×

EVIGATOR 1

What we do 1 What sets us apart 1 Our solutions 1 What we think 1
×

Global RWE 2

What we do 2 What sets us apart 2 Our solutions 2 What we think 2
×

Strategic Services 3

What we do 3 What sets us apart 3 Our solutions 3 What we think 3
0
Skip to Content
GIPAM
Why GIPAM
About
Corporate Responsibility
Careers
Services
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Insights
News
Whitepapers & Publications
Events & Webinars
Ask me about RWE
Contact
Subscribe to Newsletter
Shop
GIPAM
Why GIPAM
About
Corporate Responsibility
Careers
Services
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Insights
News
Whitepapers & Publications
Events & Webinars
Ask me about RWE
Contact
Subscribe to Newsletter
Shop
Folder: Why GIPAM
Back
About
Corporate Responsibility
Careers
Folder: Services
Back
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Folder: Insights
Back
News
Whitepapers & Publications
Events & Webinars
Ask me about RWE
Contact
Subscribe to Newsletter
Shop
Shop Feasibility of a GER claims Data study (such as FDZ;note: AOK PLUS and GWQ data not included here))
Review 1.png Image 1 of
Review 1.png
Review 1.png

Feasibility of a GER claims Data study (such as FDZ;note: AOK PLUS and GWQ data not included here))

€15,000.00

Assess available variables and possibility to identify target patient samples in a GER claims data set.


Included:

  • Kick-off

  • Synopsis

  • Assessment based on previous studies and in-depth knowledge of GER claims data.

Note that AOK PLUS and GWQ datasets cannot be addressed in this format.

Timeline: 2-4 weeks

Quantity:
Add To Cart

Assess available variables and possibility to identify target patient samples in a GER claims data set.


Included:

  • Kick-off

  • Synopsis

  • Assessment based on previous studies and in-depth knowledge of GER claims data.

Note that AOK PLUS and GWQ datasets cannot be addressed in this format.

Timeline: 2-4 weeks

Assess available variables and possibility to identify target patient samples in a GER claims data set.


Included:

  • Kick-off

  • Synopsis

  • Assessment based on previous studies and in-depth knowledge of GER claims data.

Note that AOK PLUS and GWQ datasets cannot be addressed in this format.

Timeline: 2-4 weeks

You Might Also Like

Development of a full-text manuscript for a RWE study
Development of a full-text manuscript for a RWE study
€27,000.00
Development of a SAP for a RWE study (retrospective study design)
Development of a SAP for a RWE study (retrospective study design)
€29,000.00
Development of a Study Protocol for a RWE study (retrospective study design)
Development of a Study Protocol for a RWE study (retrospective study design)
€24,000.00
Review of an existing RWE study SAP
Review of an existing RWE study SAP
€6,500.00
Review of licensed data assets
Review of licensed data assets
€64,000.00

Do you have questions?

CONTACT US >

Contact Us

GIPAM GmbH

Alter Holzhafen 19

23966 Wismar, Germany

Phone: +49 3841 758 1014

info@gipam-health.com

Shop Form
Please provide your contact details and we will contact you about your wishlist
Name *

Thank you for your submission.

As you’ll likely need a full contract, we’ll send you a draft within the next 48 working hours. Once received, please review the draft carefully. If you're happy to proceed, you can either sign it directly or let us know if you’d prefer to use an electronic signature process.

Should you have any feedback or request changes, we’re happy to consider them—please email Sabrina at sabrina.mueller@gipam-health.com.

Once the contract is signed, our project manager will be in touch right away to schedule your kick-off meeting.

Our Services

Strategic Services

Global RWE

Evidence Synthesis

Ask me about RWE

Learn more

News & Seminars

Whitepapers & Publications

About Us

Corporate Responsibility

Code of Conduct

Privacy Policy

Cookie Policy

Terms of Use

Connect